Beyond Conventional Therapies: What’s Next for the Myasthenia...

a adăugat un sunet Alte

2026-08-14 05:48:07 - Translate -

Beyond Conventional Therapies: What’s Next for the Myasthenia Gravis Disease Treatment Market?

According to a new report by Polaris Market Research, the global Myasthenia Gravis Disease Treatment market was valued at USD 2.53 billion in 2025 and is projected to reach USD 5.49 billion by 2034, expanding at a CAGR of 9.00% over the 2026–2034 forecast period. Growth is underpinned by rising disease prevalence, expanding adoption of targeted biologic therapies, and favorable...

0 Commentarii 0 Distribuiri 3 Views 0 previzualizare